Uojima, H., Chuma, M., Tanaka, Y., Hidaka, H., Nakazawa, T., Iwabuchi, S., . . . Koizumi, W. (2020). Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib. Liver Cancer.
Chicago Style CitationUojima, Haruki, et al. "Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated With Lenvatinib." Liver Cancer 2020.
Cita MLAUojima, Haruki, et al. "Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated With Lenvatinib." Liver Cancer 2020.
Atenció: Aquestes cites poden no estar 100% correctes.